You are here

  • Home
  • Archive
  • Volume 100, Issue 10
  • Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration

Article metrics

Article menu
Download PDFPDF
Clinical science
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration

 

Online download statistics by month:

Online download statistics by month: January 2016 to March 2024

AbstractFullPdf
Jan 201634449152
Feb 20161262649
Mar 2016791228
Apr 2016641922
May 20161041631
Jun 2016307923
Jul 201656719
Aug 20161012221
Sep 20165383073
Oct 20169933097
Nov 201624425117
Dec 2016171525
Jan 20171101317
Feb 2017802127
Mar 2017833225
Apr 2017491311
May 2017622317
Jun 2017583020
Jul 201772812
Aug 20171232016
Sep 20172292315
Oct 20173901521
Nov 20172473217
Dec 2017156349
Jan 2018160247
Feb 2018113245
Mar 2018153277
Apr 2018992911
May 2018138183
Jun 201880204
Jul 201886285
Aug 201886252
Sep 201879284
Oct 2018104189
Nov 201883176
Dec 201886174
Jan 201964187
Feb 2019892014
Mar 20197423
Apr 2019681312
May 201971135
Jun 201945195
Jul 201977174
Aug 201952203
Sep 201967239
Oct 201962175
Nov 201978173
Dec 201954162
Jan 202055154
Feb 202065205
Mar 202055183
Apr 202051243
May 202056254
Jun 20201011814
Jul 2020100198
Aug 202053217
Sep 202075151
Oct 202062189
Nov 20205221
Dec 20208901
Jan 20215732
Feb 20217136
Mar 20217331
Apr 20213731
May 20212772
Jun 2021613
Jul 2021113
Aug 2021443
Sep 20211188
Oct 20213133
Nov 20213243
Dec 20212511
Jan 20225069
Feb 20224245
Mar 20225800
Apr 20223221
May 20226940
Jun 20227335
Jul 20228566
Aug 20227350
Sep 20224411
Oct 20227953
Nov 20224982
Dec 20224710
Jan 20237321
Feb 20238740
Mar 20231821
Apr 20232740
May 20233832
Jun 20233822
Jul 20233512
Aug 20234221
Sep 20236810
Oct 202316242
Nov 20234612
Dec 20234610
Jan 20244211
Feb 20241610
Mar 20243552
Total951712991147